BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5933915)

  • 1. Some problems of the penicillamine action in hepatolenticular degeneration.
    Chromy K; Heyrovsky A
    Metabolism; 1966 Jun; 15(6):529-36. PubMed ID: 5933915
    [No Abstract]   [Full Text] [Related]  

  • 2. [Wilson's disease. 2 cases with damage to liver cells and renal tubules treated with penicillamine].
    Gregersen G; Frederiksen G
    Ugeskr Laeger; 1971 Jul; 133(29):1406-9. PubMed ID: 5569040
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of penicillamine on serum iron.
    Walshe JM; Patston V
    Arch Dis Child; 1965 Dec; 40(214):651-3. PubMed ID: 5844954
    [No Abstract]   [Full Text] [Related]  

  • 4. [Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine].
    Lange J; Brandt G
    Med Welt; 1981 Jan; 32(3):109-10. PubMed ID: 7207132
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of penicillamine therapy and low-copper diet on dysarthria in Wilson's disease (hepatolenticular degeneration).
    Berry WR; Aronson AE; Darley FL; Goldstein NP
    Mayo Clin Proc; 1974 Jun; 49(6):405-8. PubMed ID: 4835812
    [No Abstract]   [Full Text] [Related]  

  • 6. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
    Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
    [No Abstract]   [Full Text] [Related]  

  • 7. Penicillamine in Wilson's disease.
    Danks DM
    Lancet; 1982 Aug; 2(8295):435-6. PubMed ID: 6124819
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
    Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV
    Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484
    [No Abstract]   [Full Text] [Related]  

  • 9. Wilson's disease: the role of penicillamine.
    Carmichael BM
    Mil Med; 1969 Oct; 134(11):1336-9. PubMed ID: 4980975
    [No Abstract]   [Full Text] [Related]  

  • 10. [Penicillamine treatment of Wilson's disease].
    Falkmer S; Samuelson G; Sjölin S
    Lakartidningen; 1969 May; 66(20):2097-105. PubMed ID: 5795695
    [No Abstract]   [Full Text] [Related]  

  • 11. The physiology of copper in man and its relation to Wilson's disease.
    Walshe JM
    Brain; 1967 Mar; 90(1):149-76. PubMed ID: 5336999
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of penicillamine on failure of renal acidification in Wilson's disease.
    Walshe JM
    Lancet; 1968 Apr; 1(7546):775-8. PubMed ID: 4171128
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies with radioactive copper (64Cu and 67Cu) in relation to the natural history of Wilson's disease.
    Osborn SB; Walshe JM
    Lancet; 1967 Feb; 1(7486):346-50. PubMed ID: 4163882
    [No Abstract]   [Full Text] [Related]  

  • 14. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
    Falkmer S; Samuelson G; Sjölin S
    Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of Wilson's disease.
    Brewer GJ; Yuzbasiyan-Gurkan V; Young AB
    Semin Neurol; 1987 Jun; 7(2):209-20. PubMed ID: 3332455
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term treatment of Wilson's disease with D-penicillamine. Report on 20 cases].
    Lange J
    Dtsch Med Wochenschr; 1967 Sep; 92(37):1657-62. PubMed ID: 6054323
    [No Abstract]   [Full Text] [Related]  

  • 17. The discovery of the therapeutic use of D-penicillamine.
    Walshe JM
    J Rheumatol Suppl; 1981; 7():3-8. PubMed ID: 7014875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatolenticular degeneration: the comparative effectiveness of d-penicillamine, potassium sulfide, and diethylditbiocarbamate as decoppering agents.
    Hsia YE; Combs JT; Hook L; Brandt IK
    J Pediatr; 1966 Jun; 68(6):921-6. PubMed ID: 5327103
    [No Abstract]   [Full Text] [Related]  

  • 19. Some therapeutic observations in Wilson's disease.
    Shoulson I; Goldblatt D; Plassche W; Wilson G
    Adv Neurol; 1983; 37():239-46. PubMed ID: 6858775
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
    Marecek Z; Heyrovský A; Volek V
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.